ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1046
0,00%
Bitcoin
67.262,18
0,27%
Brent Oil
83,76
0,00%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. (MM) (GEVA)

  7. (MM) (GEVA) Notícias

GEVA

(MM) (GEVA)

(MM)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:GEVA
DataHoraFonteTítuloCódigoCompanhia
06/07/201513:14Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:GEVA(MM)
29/06/201518:31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:GEVA(MM)
24/06/201510:44Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:GEVA(MM)
24/06/201507:06Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:GEVA(MM)
23/06/201518:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GEVA(MM)
23/06/201509:55Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GEVA(MM)
23/06/201509:21Edgar (US Regulatory)(25-NSE)NASDAQ:GEVA(MM)
23/06/201509:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GEVA(MM)
23/06/201507:30Business WireAlexion Completes Acquisition of SynagevaNASDAQ:GEVA(MM)
22/06/201509:54Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:GEVA(MM)
22/06/201509:32Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:GEVA(MM)
22/06/201509:31Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:GEVA(MM)
10/06/201512:32Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GEVA(MM)
04/06/201517:05PR Newswire (US)Synageva BioPharma Completes Targeted Enrollment in Phase 1/2 Trial with SBC-103 for Mucopolysaccharidosis IIIBNASDAQ:GEVA(MM)
02/06/201520:29Business WireSHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Synageva BioPharma Corp.NASDAQ:GEVA(MM)
26/05/201517:05PR Newswire (US)Synageva BioPharma Submits Kanuma™ (Sebelipase Alfa) Application For LAL Deficiency In JapanNASDAQ:GEVA(MM)
22/05/201517:41Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:GEVA(MM)
22/05/201517:31Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:GEVA(MM)
22/05/201512:26PR Newswire (US)SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Synageva BioPharma Corp. -GEVANASDAQ:GEVA(MM)
18/05/201517:10PR Newswire (US)SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Synageva BioPharma Corp. of Commencement of an Investigation...NASDAQ:GEVA(MM)
18/05/201515:28Business WireSYNAGEVA BIOPHARMA CORP. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Synageva BioPharma Corp. Over th...NASDAQ:GEVA(MM)
18/05/201513:18Dow Jones NewsEndo to Buy Generics Maker Par Pharma for $8 Billion -- 4th UpdateNASDAQ:GEVA(MM)
18/05/201512:05Dow Jones NewsEndo to Buy Generics Maker Par Pharma for $8 Billion -- 3rd UpdateNASDAQ:GEVA(MM)
18/05/201510:20Dow Jones NewsEndo to Buy Par PharmaNASDAQ:GEVA(MM)
18/05/201509:53Dow Jones NewsEndo to Buy Generics Maker Par Pharma for $8 Billion -- 2nd UpdateNASDAQ:GEVA(MM)
18/05/201508:44Dow Jones NewsEndo to Buy Generics Maker Par Pharma for About $8 Billion -- UpdateNASDAQ:GEVA(MM)
13/05/201517:37Business WireSHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Synageva BioPharma Corp. And Encourages ...NASDAQ:GEVA(MM)
11/05/201518:22Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:GEVA(MM)
10/05/201514:03The Motley FoolInvestors Just Doubled Their Money on This StockNASDAQ:GEVA(MM)
10/05/201512:06The Motley FoolWill Suitors Line Up to Buy These Biotech Stocks Next?NASDAQ:GEVA(MM)
 Apresentando as notícias mais relevantes sobre:NASDAQ:GEVA

Seu Histórico Recente

AMEX
LVHI
Franklin International L...
EU
BEAR00423382
Aspa
NASDAQ
ESEAV
TSXV
CROW.P
Stormcrow
USOTC
NVLIF
Nova Lithium (PK)
LSE
AT42
Cred Ag Co 28
BIT
INFU
ETF
BOV
C2AC34
Caci
NYSE
ARP-E
AMEX
QMAR
FT Vest Nasdaq 100 Buffe...
NASDAQ
BRIL
NASDAQ
FZJUUX
Senior Loan & Limited Du...
EU
ANTIN
Antin Infrastructure Par...
COIN
DEFTEUR
CSE
PLCN
Cannibble Food Tech
LSE
KSS
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados